‘Diabetes drug cuts cardiovascular, kidney problems’
A clinical trial that followed more than 9,900 people in 24 countries has found that the drug dulaglutide reduced cardiovascular events and kidney problems in middle-aged and older people with Type 2 diabetes.
Keeping A Healthy Heart
Cardiovascular disease (CVD) continues to be the world's biggest killer accounting for one in three of all deaths; so little wonder a new drug-stated as the biggest breakthrough since statins has been hailed as a new dawn in heart treatment. In Nigeria, more than 100,000 people will suffer a heart attack every year, but until…